华纳药厂
(688799)
| 流通市值：74.97亿 | | | 总市值：74.97亿 |
| 流通股本：1.34亿 | | | 总股本：1.34亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 660,691,577.24 | 324,546,325.12 | 1,504,231,254.46 | 1,085,824,496.38 |
| 营业总成本 | 593,388,043.18 | 292,515,876.27 | 1,359,745,544.14 | 966,629,718.63 |
| 其他经营收益 | | | | |
| 营业利润 | 74,781,560.6 | 33,189,779.01 | 240,484,942.22 | 216,523,407.34 |
| 利润总额 | 74,579,933.77 | 33,188,649.26 | 240,895,081 | 215,830,132.74 |
| 净利润 | 64,599,830 | 26,876,979.68 | 228,098,328.6 | 196,942,553.29 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 64,599,830 | 26,876,979.68 | 228,098,328.6 | 196,942,553.29 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,129,644,491.22 | 1,106,687,552.08 | 1,176,225,379.93 | 1,426,300,751.46 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,309,170,841.63 | 2,133,487,631.94 | 1,877,418,088.93 | 1,354,543,424.13 |
| 资产总计 | 3,438,815,332.85 | 3,240,175,184.02 | 3,053,643,468.86 | 2,780,844,175.59 |
| 流动负债: | | | | |
| 流动负债合计 | 439,303,793.76 | 391,168,967.12 | 410,702,784.87 | 334,762,565.42 |
| 非流动负债: | | | | |
| 非流动负债合计 | 875,795,368.08 | 773,175,454.01 | 600,255,786.38 | 453,961,380.22 |
| 负债合计 | 1,315,099,161.84 | 1,164,344,421.13 | 1,010,958,571.25 | 788,723,945.64 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,123,716,171.01 | 2,075,830,762.89 | 2,042,684,897.61 | 1,992,120,229.95 |
| 股东权益合计 | 2,123,716,171.01 | 2,075,830,762.89 | 2,042,684,897.61 | 1,992,120,229.95 |
| 负债和股东权益合计 | 3,438,815,332.85 | 3,240,175,184.02 | 3,053,643,468.86 | 2,780,844,175.59 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 606,243,909.74 | 319,304,553.27 | 1,397,762,072.38 | 1,085,609,543.33 |
| 经营活动现金流出小计 | 439,508,923.89 | 246,251,535.65 | 1,097,561,561.72 | 879,301,082.47 |
| 经营活动产生的现金流量净额 | 166,734,985.85 | 73,053,017.62 | 300,200,510.66 | 206,308,460.86 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 577,769,140.21 | 100,183,567.85 | 651,180,864.88 | 486,231,065.33 |
| 投资活动现金流出小计 | 942,403,768.98 | 358,689,970.43 | 1,260,355,569.51 | 867,395,039.65 |
| 投资活动产生的现金流量净额 | -364,634,628.77 | -258,506,402.58 | -609,174,704.63 | -381,163,974.32 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 764,089,884.71 | 174,398,227 | 398,970,229.4 | 253,226,643.74 |
| 筹资活动现金流出小计 | 480,091,774.86 | 3,817,650.12 | 62,964,210.34 | 59,762,262.25 |
| 筹资活动产生的现金流量净额 | 283,998,109.85 | 170,580,576.88 | 336,006,019.06 | 193,464,381.49 |
| 汇率变动对现金及现金等价物的影响 | -1,366,483.74 | -645,151.4 | -993,338.01 | -407,517.58 |
| 现金及现金等价物净增加额 | 84,731,983.19 | -15,517,959.48 | 26,038,487.08 | 18,201,350.45 |
| 期末现金及现金等价物余额 | 286,210,410.85 | 185,960,468.18 | 201,478,427.66 | 193,641,291.03 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 84,731,983.19 | - | 26,038,487.08 | - |